Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc.（RKDA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RKDA · 截至 2026年6月8日
活动摘要
买入笔数
6
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Arcadia Biosciences, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
RKDA 季度内部人买卖趋势
RKDA 内幕交易卖出 · RKDA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
近期内幕交易记录
RKDA 高管卖出股份 · RKDA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 3, 2025 | Kawakami Mark CFO | Purchase | 700 | $2K | Form 4 |
| Feb 3, 2025 | Schaefer Thomas J. CEO | Purchase | 700 | $2K | Form 4 |
| Aug 1, 2024 | Kawakami Mark CFO | Purchase | 700 | $1K | Form 4 |
| Aug 1, 2024 | Schaefer Thomas J. CEO | Purchase | 700 | $1K | Form 4 |
| Feb 1, 2024 | Schaefer Thomas J. CFO | Purchase | 700 | $1K | Form 4 |
| Aug 4, 2023 | Schaefer Thomas J. CFO | Purchase | 649 | $2K | Form 4 |
| Feb 1, 2023 | Schaefer Thomas J. CFO | Purchase | 700 | $161 | Form 4 |
| Aug 1, 2022 | Haley Pamela CFO | Purchase | 700 | $490 | Form 4 |
| Aug 3, 2020 | Plavan Matthew T CEO | Purchase | 585 | $2K | Form 4 |
| Aug 3, 2020 | Shultz Randall CTO | Purchase | 700 | $2K | Form 4 |
| Aug 3, 2020 | Haley Pamela CFO | Purchase | 700 | $2K | Form 4 |
| Feb 3, 2020 | Haley Pamela CFO | Purchase | 700 | $1K | Form 4 |
| Feb 3, 2020 | Reiter Sarah Chief Commercial Officer | Purchase | 700 | $1K | Form 4 |
| Feb 3, 2020 | Plavan Matthew T CEO | Purchase | 700 | $1K | Form 4 |
| Dec 23, 2019 | Reiter Sarah Chief Commercial Officer | Purchase | 900 | $5K | Form 4 |
| Nov 19, 2019 | Reiter Sarah Chief Commercial Officer | Purchase | 1,000 | $5K | Form 4 |
| Sep 23, 2019 | Plavan Matthew T CEO | Purchase | 2,000 | $11K | Form 4 |
| Sep 17, 2019 | Comcowich Kevin Director | Purchase | 5,000 | $29K | Form 4 |
| Sep 10, 2019 | Plavan Matthew T CEO | Purchase | 1,000 | $7K | Form 4 |
| Sep 10, 2019 | Plavan Matthew T CEO | Purchase | 1,000 | $6K | Form 4 |
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RKDA 内幕交易
RKDA 内幕交易
Arcadia Biosciences, Inc.（RKDA）内幕交易数据来源于公司内部人（包括RKDA）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。RKDA内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Arcadia Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RKDA 内幕交易 · 5个问题Arcadia Biosciences, Inc.（RKDA）的内部人包括高管和董事，如RKDA等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026